CLINICAL_TRIALS
trial_result
· 2012-05-07
Clinical Trial Update: A Study to Evaluate the Effect of Vildagliptin on the Maximum Insulin Secretion in Patients With Type 2 Diabetes [Phase 3]
Summary
A Phase 3 trial evaluating the effect of vildagliptin on maximum insulin secretion in patients with Type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED